Archive
All News
Every briefing, headline, and filing we've published, newest first.
The WeekPharmaVoice ↗
Late-stage drugs in pancreatic cancer, multiple myeloma and Alzheimer's could pair treatment advances with maj…
The WeekFiercePharma ↗
Daiichi Sankyo is promoting Ken Keller to lead a new globally integrated commercialization unit, putting the e…
The WeekFierceBiotech ↗
Roche has taken its obesity strategy into uncharted territory via a $190 million upfront payment for a clinica…
The WeekBriefing
Ultragenyx secured clearance for Genglycos in a rare glycogen storage disease. The immediate value is commerci…
The WeekPharmaceutical Technology ↗
Gossamer Bio has announced a private placement agreement valued at up to $250m, including $150m of committed c…
The WeekBioPharma Dive ↗
AI is changing how HCPs seek answers. Pharma marketers need a new strategy.…
The WeekSTAT News ↗
Moderna and Merck's wild gambit on a cancer vaccine appears to have worked, despite big doubts, logistical cha…
The WeekFiercePharma ↗
In this tracker, Fierce Pharma is recording the regulatory progress of in-market products, including expansion…
The WeekFierceBiotech ↗
Joshua Pinto, Ph.D., has been appointed chief executive officer of Neumora Therapeutics, a clinical-stage biot…
The WeekBriefing
Vitestro’s Aletta won FDA approval as the first standalone robotic blood-draw device in the U.S. designed to o…
The WeekFiercePharma ↗
Almost three years into his tenure as Lundbeck's CEO, Charl van Zyl is confident the company can prove its met…
The WeekFierceBiotech ↗
Werewolf Therapeutics' hunt for strategic alternatives has ended. Ambros Therapeutics has agreed to merge with…
The WeekBriefing
Genglycos won accelerated approval on August 19 as the first approved treatment for glycogen storage disease t…
The WeekKFF Health News ↗
Last updated on August 21, 2026 Since the Supreme Court's Dobbs decision, overturning Roe v. Wade, voters in 1…
The WeekSTAT News ↗
Kennedy asks for feedback on new vaccine recommendation categories, how shots are tested.…
The WeekSTAT News ↗
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmace…
The WeekBioPharma Dive ↗
Kaos Capital wants a "governance reset" to alter the Duchenne cell therapy maker's strategic course. Elsewhere…
The WeekPharmaVoice ↗
What started as two neighbors trading shop talk has grown into Tyra Biosciences, a clinical-stage biotech comp…
The WeekBioPharma Dive ↗
As Eli Lilly and Novo Nordisk race for share, surveys show affordability and prescribing preferences may help …
The WeekPharmaceutical Technology ↗
Roche's Oregon fill-finish site will produce both autoinjectors and pre-filled syringes - serving its pipeline…
The WeekFiercePharma ↗
Regeneron's "Science Illuminated" podcast series transforms scientific topics into a calming, meditative-style…
The WeekFierceBiotech ↗
Boehringer Ingelheim has suspended a phase 1 trial of an investigational small molecule drug while it seeks to…
The WeekBriefing
FDA’s new PDUFA VII deliverables page is a compliance snapshot, not a policy shift. The read-through is on exe…
The WeekDrug Channels ↗
Today's guest post comes from Jay Weaver, VP, Payer Solutions at PANTHERx® Rare. Jay describes the clinical an…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.